17314120

Source:http://linkedlifedata.com/resource/pubmed/id/17314120

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001617, umls-concept:C0003873, umls-concept:C0023779, umls-concept:C0087111, umls-concept:C0392747, umls-concept:C0443172, umls-concept:C0666743, umls-concept:C1979963, umls-concept:C2003903
pubmed:issue	7
pubmed:dateCreated	2007-6-19
pubmed:abstractText	To evaluate the effects of infliximab and corticosteroid treatment on the lipid profile in patients with active rheumatoid arthritis (RA).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-10438259, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-10451065, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-10941819, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-11953961, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-11955534, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-12117731, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-12124853, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-12208376, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-12620753, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-12922956, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-14676136, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-14705214, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-14746556, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-15231512, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-15338494, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-15469034, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-15488873, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-15693084, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-15843671, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-16331755, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-3536151, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-3773200, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-7743622, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-7818570, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-7944071, http://linkedlifedata.com/resource/pubmed/commentcorrection/17314120-9227167
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0003-4967
pubmed:author	pubmed-author:DijkmansB A CBA, pubmed-author:LemsW FWF, pubmed-author:NurmohamedM TMT, pubmed-author:PetersM J LMJ, pubmed-author:TwiskJ W RJW, pubmed-author:VisMM, pubmed-author:VoskuylA EAE, pubmed-author:WolbinkG JGJ, pubmed-author:de KoningM H M TMH, pubmed-author:van HalmV PVP, pubmed-author:van de StadtR JRJ
pubmed:issnType	Print
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	958-61
pubmed:dateRevised	2010-9-14
pubmed:meshHeading	pubmed-meshheading:17314120-Antibodies, Monoclonal, pubmed-meshheading:17314120-Antirheumatic Agents, pubmed-meshheading:17314120-Apolipoproteins, pubmed-meshheading:17314120-Arthritis, Rheumatoid, pubmed-meshheading:17314120-C-Reactive Protein, pubmed-meshheading:17314120-Cholesterol, pubmed-meshheading:17314120-Cholesterol, HDL, pubmed-meshheading:17314120-Drug Administration Schedule, pubmed-meshheading:17314120-Drug Therapy, Combination, pubmed-meshheading:17314120-Female, pubmed-meshheading:17314120-Glucocorticoids, pubmed-meshheading:17314120-Humans, pubmed-meshheading:17314120-Immunosuppressive Agents, pubmed-meshheading:17314120-Lipids, pubmed-meshheading:17314120-Longitudinal Studies, pubmed-meshheading:17314120-Male, pubmed-meshheading:17314120-Methotrexate, pubmed-meshheading:17314120-Middle Aged, pubmed-meshheading:17314120-Prednisone
pubmed:year	2007
pubmed:articleTitle	Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
pubmed:affiliation	Department of Rheumatology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
pubmed:publicationType	Journal Article